Pacer Advisors, Inc. Novartis Ag Transaction History

Pacer Advisors, Inc.

$40.5 Billion
Q4 2024

A detailed history of Pacer Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Pacer Advisors, Inc. holds 400,010 shares of NVS stock, worth $40 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

400,010

Previous 385,002 3.9%

Holding current value

$40 Million

Previous $44.3 Million 12.1%

% of portfolio

0.1%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$96.78 - $117.18 $1.45 Million - $1.76 Million	15,008 Added 3.9%	400,010 $38.9 Million
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $1.05 Million - $1.2 Million	9,934 Added 2.65%	385,002 $44.3 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $1.69 Million - $1.96 Million	-18,268 Reduced 4.64%	375,068 $39.9 Million
Q1 2024 May 10, 2024	BUY	$95.27 - $108.47 $525,509 - $598,320	5,516 Added 1.42%	393,336 $38 Million
Q4 2023 Jan 16, 2024	BUY	$92.27 - $101.54 $34 Million - $37.4 Million	368,778 Added 1936.66%	387,820 $39.2 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $105,529 - $117,114	-1,114 Reduced 5.53%	19,042 $1.94 Million
Q2 2023 Jul 12, 2023	SELL	$92.52 - $104.91 $29 Million - $32.9 Million	-313,159 Reduced 93.95%	20,156 $2.03 Million
Q1 2023 May 02, 2023	BUY	$80.03 - $92.81 $8.04 Million - $9.33 Million	100,479 Added 43.15%	333,315 $30.7 Million
Q4 2022 Feb 06, 2023	BUY	$75.55 - $92.52 $3.8 Million - $4.65 Million	50,296 Added 27.55%	232,836 $21.1 Million
Q3 2022 Oct 18, 2022	BUY	$74.61 - $87.26 $3.31 Million - $3.87 Million	44,305 Added 32.05%	182,540 $13.9 Million
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $6.26 Million - $7.29 Million	77,785 Added 128.68%	138,235 $11.7 Million
Q1 2022 Apr 05, 2022	BUY	$80.11 - $90.62 $760,324 - $860,074	9,491 Added 18.62%	60,450 $5.3 Million
Q4 2021 Feb 03, 2022	BUY	$79.7 - $88.13 $56,587 - $62,572	710 Added 1.41%	50,959 $4.46 Million
Q3 2021 Oct 15, 2021	SELL	$81.78 - $95.14 $35,574 - $41,385	-435 Reduced 0.86%	50,249 $4.11 Million
Q2 2021 Jul 21, 2021	BUY	$85.24 - $94.15 $463,194 - $511,611	5,434 Added 12.01%	50,684 $4.62 Million
Q1 2021 Apr 05, 2021	SELL	$83.5 - $98.47 $185,119 - $218,307	-2,217 Reduced 4.67%	45,250 $3.87 Million
Q4 2020 Jan 20, 2021	BUY	$78.07 - $94.43 $1.78 Million - $2.15 Million	22,799 Added 92.42%	47,467 $4.48 Million
Q3 2020 Oct 19, 2020	BUY	$82.14 - $91.0 $2.03 Million - $2.24 Million	24,668 New	24,668 $2.15 Million
Q1 2020 Apr 23, 2020	SELL	$70.67 - $99.01 $1.38 Million - $1.93 Million	-19,498 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $483,915 - $547,137	5,737 Added 41.69%	19,498 $1.85 Million
Q3 2019 Oct 10, 2019	BUY	$85.54 - $94.26 $411,618 - $453,579	4,812 Added 53.77%	13,761 $1.2 Million
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $674,754 - $830,467	8,949 New	8,949 $817,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $3.79 Million - $4.22 Million	-51,460 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $285,833 - $330,626	4,270 Added 9.05%	51,460 $4.43 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $478,711 - $541,030	7,375 Added 18.52%	47,190 $3.57 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $797,237 - $953,082	11,326 Added 39.76%	39,815 $3.22 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $359,986 - $386,414	4,977 Added 21.17%	28,489 $2.39 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $1.74 Million - $1.82 Million	23,512	23,512 $2.02 Million

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Novartis Ag Transaction History